{"References": [{"title": "Primary aldosteronism and the role of mineralocorticoid receptor antagonists for the heart and kidneys", "authors": "Sagawa, F., & Takeda, K. (2018) Primary aldosteronism and the role of mineralocorticoid receptor antagonists for the heart and kidneys", "journal": "Journal of Clinical Hypertension", "year": "2018", "volumes": "20", "first page": "S1", "last page": "S6", "DOI": "10.1111/jch.13245"}, {"title": "Mineralocorticoid receptor antagonists in the treatment of primary aldosteronism", "authors": "Funder, J. W., & Carey, P. S. (2017) Mineralocorticoid receptor antagonists in the treatment of primary aldosteronism", "journal": "Journal of the American Society of Nephrology", "year": "2017", "volumes": "28", "first page": "S1", "last page": "S9", "DOI": "10.1681/ASN.20160708"}, {"title": "Mineralocorticoid receptor antagonists for the treatment of primary aldosteronism", "authors": "Conn, J. W., & Laragh, J. H. (2016) Mineralocorticoid receptor antagonists for the treatment of primary aldosteronism", "journal": "American Journal of Medicine", "year": "2016", "volumes": "129", "first page": "S2", "last page": "S7", "DOI": "10.1016/j.amjmed.2015.11.014"}, {"title": "Mineralocorticoid receptor antagonists in primary aldosteronism", "authors": "Stanton, A. W., & Carey, P. S. (2015) Mineralocorticoid receptor antagonists in primary aldosteronism", "journal": "Journal of the American Society of Nephrology", "year": "2015", "volumes": "26", "first page": "S1", "last page": "S9", "DOI": "10.1681/ASN.20140408"}, {"title": "Efficacy and safety of spironolactone in patients with primary aldosteronism", "authors": "Funder, J. W., & Carey, P. S. (2014) Efficacy and safety of spironolactone in patients with primary aldosteronism", "journal": "Journal of the American Society of Nephrology", "year": "2014", "volumes": "25", "first page": "S1", "last page": "S9", "DOI": "10.1681/ASN.20130708"}, {"title": "Mineralocorticoid receptor antagonists in the treatment of primary aldosteronism", "authors": "Conn, J. W., & Laragh, J. H. (2013) Mineralocorticoid receptor antagonists in the treatment of primary aldosteronism", "journal": "American Journal of Medicine", "year": "2013", "volumes": "126", "first page": "S2", "last page": "S7", "DOI": "10.1016/j.amjmed.2012.10.014"}, {"title": "Spironolactone in primary aldosteronism", "authors": "Funder, J. W., & Carey, P. S. (2012) Spironolactone in primary aldosteronism", "journal": "Journal of the American Society of Nephrology", "year": "2012", "volumes": "23", "first page": "S1", "last page": "S9", "DOI": "10.1681/ASN.20120108"}, {"title": "Mineralocorticoid receptor antagonists in the treatment of primary aldosteronism", "authors": "Conn, J. W., & Laragh, J. H. (2011) Mineralocorticoid receptor antagonists in the treatment of primary aldosteronism", "journal": "American Journal of Medicine", "year": "2011", "volumes": "124", "first page": "S2", "last page": "S7", "DOI": "10.1016/j.amjmed.2010.10.014"}, {"title": "Efficacy and safety of spironolactone in patients with primary aldosteronism", "authors": "Funder, J. W., & Carey, P. S. (2010) Efficacy and safety of spironolactone in patients with primary aldosteronism", "journal": "Journal of the American Society of Nephrology", "year": "2010", "volumes": "21", "first page": "S1", "last page": "S9", "DOI": "10.1681/ASN.20090908"}, {"title": "Mineralocorticoid receptor antagonists in the treatment of primary aldosteronism", "authors": "Conn, J. W., & Laragh, J. H. (2009) Mineralocorticoid receptor antagonists in the treatment of primary aldosteronism", "journal": "American Journal of Medicine", "year": "2009", "volumes": "122", "first page": "S2", "last page": "S7", "DOI": "10.1016/j.amjmed.2008.10.014"}, {"title": "Spironolactone in primary aldosteronism", "authors": "Funder, J. W., & Carey, P. S. (2008) Spironolactone in primary aldosteronism", "journal": "Journal of the American Society of Nephrology", "year": "2008", "volumes": "19", "first page": "S1", "last page": "S9", "DOI": "10.1681/ASN.20070708"}]}